HomeCompareRLYNF vs JNJ

RLYNF vs JNJ: Dividend Comparison 2026

RLYNF yields 1333.33% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RLYNF wins by $3.52M in total portfolio value
10 years
RLYNF
RLYNF
● Live price
1333.33%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.55M
Annual income
$23,370.23
Full RLYNF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — RLYNF vs JNJ

📍 RLYNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRLYNFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RLYNF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RLYNF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RLYNF
Annual income on $10K today (after 15% tax)
$113,333.33/yr
After 10yr DRIP, annual income (after tax)
$19,864.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, RLYNF beats the other by $15,878.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RLYNF + JNJ for your $10,000?

RLYNF: 50%JNJ: 50%
100% JNJ50/50100% RLYNF
Portfolio after 10yr
$1.79M
Annual income
$14,029.82/yr
Blended yield
0.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RLYNF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RLYNF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRLYNFJNJ
Forward yield1333.33%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$3.55M$30.3K
Annual income after 10y$23,370.23$4,689.40
Total dividends collected$2.41M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RLYNF vs JNJ ($10,000, DRIP)

YearRLYNF PortfolioRLYNF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$77,367$66,666.67$10,592$272.30+$66.8KRLYNF
2$323,800$241,017.65$11,289$357.73+$312.5KRLYNF
3$817,832$471,365.75$12,123$472.89+$805.7KRLYNF
4$1,431,409$556,328.59$13,141$629.86+$1.42MRLYNF
5$1,986,613$455,006.14$14,408$846.81+$1.97MRLYNF
6$2,420,765$295,089.13$16,021$1,151.60+$2.40MRLYNF
7$2,758,246$168,026.89$18,122$1,588.22+$2.74MRLYNF
8$3,040,786$89,463.38$20,930$2,228.20+$3.02MRLYNF
9$3,299,729$46,087.64$24,792$3,191.91+$3.27MRLYNF
10$3,554,080$23,370.23$30,274$4,689.40+$3.52MRLYNF

RLYNF vs JNJ: Complete Analysis 2026

RLYNFStock

Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Latin America mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment and management, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. As of December 31, 2021, Rallye SA operates as a subsidiary of Foncière Euris SA.

Full RLYNF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RLYNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RLYNF vs SCHDRLYNF vs JEPIRLYNF vs ORLYNF vs KORLYNF vs MAINRLYNF vs ABBVRLYNF vs MRKRLYNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.